Wockhardt in trouble with USFDA

Mint 2018-02-16

Views 17

According to a letter from the FDA to Wockhardt chairman Habil Khorakiwala, there is a larger problem at the drug-maker than just manufacturing compliance issues. Mint's CH Unnikrishnan shares the details with Zahra Khan.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
From the newsroom: Fortune smiles on Wockhardt again
play
04:42

From the newsroom: Fortune smiles on Wockhardt again
FDA charges data integrity issues in Wockhardt factories
play
03:33

FDA charges data integrity issues in Wockhardt factories
Fuelling trouble
play
01:08

Fuelling trouble
Fuelling trouble
play
01:08

Fuelling trouble
What’s the trouble with the Chinese market?
play
01:32

What’s the trouble with the Chinese market?
Matunga garden flyover faces teething troubles
play
01:52

Matunga garden flyover faces teething troubles
Indian IT companies face twin trouble
play
03:00

Indian IT companies face twin trouble
News Package: Does private equity get retailers into troubles?
play
03:15

News Package: Does private equity get retailers into troubles?
Fuel trouble
play
01:02

Fuel trouble
SKS in trouble
play
00:51

SKS in trouble
The rupee's troubles
play
01:14

The rupee's troubles
Ad trouble
play
01:50

Ad trouble